Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era

Dados Bibliográficos

ID9105078
AutoresShashi N Kapadia (0000-0001-6363-2839, Division of Infectious Diseases, autor correspondente), Phyllis Johnson (0000-0002-8594-9041, Weill Cornell Medicine), Kristen M Marks (Division of Infectious Diseases), Kristen Marks (0000-0003-1896-4978, Office of Infectious Diseases, autor correspondente), Bruce R Schackman (0000-0002-1132-2932, Weill Cornell Medicine), Yuhua Bao (0000-0002-3825-4327, Weill Cornell Medicine)
Ano2021
Volume59
Fascículo9
Páginas795-800
Data de publicação2021-09-01
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoMedical Care (JOURNAL)
Identificadores do periódicoISSN: 0025-7079 • E-ISSN: 1537-1948
EditoraOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0000000000001573
PMID34081676
OpenAlexW3164240098
IdiomaEN
Referências citadas26

BACKGROUND: Hepatitis C virus (HCV) remains under-treated in the United States and treatment by nonspecialist providers can expand access. We compare HCV treatment provision and treatment completion between nonspecialist and specialist providers. METHODS: This retrospective study used claims data from the Healthcare Cost Institute from 2013 to 2017. We identified providers who prescribed HCV therapy between 2013 and 2017, and patients enrolled in private insurance or Medicare Advantage who had pharmacy claims for HCV treatment. We measured HCV treatment completion, determined based on prescription fills for the minimum expected duration of the antiviral regimen. Using propensity score-weighted regression, we compared the likelihood of early treatment discontinuation by the type of treating provider. RESULTS: The number of providers prescribing HCV treatment peaked in 2015 and then declined. The majority were gastroenterologists, although the proportion of general medicine providers increased to 17% by 2017. Among the 23,463 patients analyzed, 1008 (4%) discontinued before the expected minimum duration. In the propensity score-weighted analysis, patients treated by general medicine physicians had similar odds of treatment discontinuation compared with those treated by gastroenterologists [odds ratio (OR)=1.00, 95% confidence interval (CI): 0.99-1.01, P=0.45]. Results were similar when comparing gastroenterologists to nonphysician providers (OR=1.00, 95% CI: 0.99-1.01, P=0.53) and infectious diseases specialists (OR=1.00, 95% CI: 0.99-1.01, P=0.71). CONCLUSIONS: HCV treatment providers remain primarily gastroenterologists, even in the current simplified treatment era. Patients receiving treatment from general medicine or nonphysician providers had a similar likelihood of treatment completion, suggesting that removing barriers to the scale-up of treatment by nonspecialists may help close treatment gaps for hepatitis C

Discontinuation · Family medicine · Hepatitis C · Hepatitis C virus · Medical prescription · Odds ratio · Propensity score matching · Regimen · Retrospective cohort study · Virus · Diabetes Management and Education · Hepatitis C virus research · Immunology · Internal Medicine · Medication Adherence and Compliance · Medicine · Pharmacy

  • Doubly Robust Estimation in Missing Data and Causal Inference Models

    Open Access•Heejung Bang, James M Robins•Biometrics•2005

  • Methods for Constructing and Assessing Propensity Scores

    Open Access•Melissa M Garrido, Amy S Kelley et al.•Health Services Research•2014

  • A tutorial on propensity score estimation for multiple treatments using generalized boosted models

    Open Access•Daniel F Mccaffrey, Beth Ann Griffin et al.•Statistics in Medicine•2013

  • Propensity Score Estimation With Boosted Regression for Evaluating Causal Effects in Observational Studies.

    Daniel F Mccaffrey, Greg Ridgeway et al.•Psychological Methods•2004

  • High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic

    Open Access•Brianna L Norton, Julia Fleming et al.•International Journal of Drug…•2017

  • Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting

    Open Access•Phillip Read, Rebecca Lothian et al.•International Journal of Drug…•2017

  • Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets

    Open Access•Naveed Z Janjua, Nazrul Islam et al.•International Journal of Drug…•2018

  • Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City

    Open Access•Czarina N Behrends, Sarah Gutkind et al.•Journal of Urban Health•2020

  • Public Health Detailing of Primary Care Providers

    Michelle G Dresser, Michelle Dresser et al.•American Journal of Public Health•2012

  • Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

    Hude Quan, Vijaya Sundararajan et al.•Medical Care•2005

Velocidade de citaçãohistorical
Altamente citadoNão
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae